Invera Wealth Advisors LLC Sells 77 Shares of CME Group Inc. (NASDAQ:CME)

Invera Wealth Advisors LLC trimmed its stake in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 2.1% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,660 shares of the financial services provider’s stock after selling 77 shares during the period. Invera Wealth Advisors LLC’s holdings in CME Group were worth $767,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Naples Global Advisors LLC grew its position in shares of CME Group by 5.6% in the 4th quarter. Naples Global Advisors LLC now owns 2,072 shares of the financial services provider’s stock valued at $436,000 after acquiring an additional 110 shares during the period. Sapient Capital LLC acquired a new position in CME Group during the fourth quarter worth approximately $1,823,000. FNY Investment Advisers LLC bought a new stake in CME Group in the fourth quarter valued at approximately $1,074,000. Deutsche Bank AG lifted its position in shares of CME Group by 4.3% in the third quarter. Deutsche Bank AG now owns 1,118,104 shares of the financial services provider’s stock valued at $223,867,000 after buying an additional 46,021 shares during the last quarter. Finally, International Assets Investment Management LLC bought a new position in shares of CME Group during the 4th quarter worth approximately $27,986,000. 87.75% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

CME has been the subject of a number of research reports. The Goldman Sachs Group cut shares of CME Group from a “neutral” rating to a “sell” rating and set a $195.00 target price for the company. in a research note on Wednesday, January 3rd. Rosenblatt Securities restated a “sell” rating and set a $187.00 price objective (up from $185.00) on shares of CME Group in a research report on Thursday. Bank of America upped their target price on CME Group from $209.00 to $216.00 and gave the company a “neutral” rating in a research report on Thursday. Argus lifted their price target on CME Group from $225.00 to $245.00 and gave the stock a “buy” rating in a report on Wednesday, March 6th. Finally, Keefe, Bruyette & Woods boosted their price target on CME Group from $222.00 to $226.00 and gave the company a “market perform” rating in a research note on Thursday. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $217.80.

Check Out Our Latest Report on CME Group

CME Group Trading Down 0.6 %

CME Group stock traded down $1.32 during trading hours on Monday, hitting $209.62. The stock had a trading volume of 1,316,666 shares, compared to its average volume of 1,782,369. The business’s 50 day simple moving average is $214.68 and its 200-day simple moving average is $211.76. CME Group Inc. has a one year low of $175.73 and a one year high of $223.80. The stock has a market cap of $75.46 billion, a price-to-earnings ratio of 23.85, a P/E/G ratio of 5.27 and a beta of 0.49. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 EPS for the quarter, topping analysts’ consensus estimates of $2.44 by $0.06. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The company had revenue of $1.49 billion for the quarter, compared to analyst estimates of $1.48 billion. During the same quarter in the previous year, the business earned $2.42 earnings per share. CME Group’s revenue was up 3.2% compared to the same quarter last year. On average, equities analysts predict that CME Group Inc. will post 9.72 EPS for the current fiscal year.

CME Group Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 26th. Investors of record on Friday, March 8th were issued a $1.15 dividend. This is a positive change from CME Group’s previous quarterly dividend of $1.10. The ex-dividend date was Thursday, March 7th. This represents a $4.60 annualized dividend and a yield of 2.19%. CME Group’s payout ratio is presently 52.33%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Read More

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.